Tatjana Vlajnic

The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support

Anja Irmisch, Ximena Bonilla, Stéphane Chevrier et al. · Cancer Cell · 2021 · 140 citations · Full text

Medicine, Bioinformatics, Oncology +17

A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer

Lucia D’Amico, Ulrike Menzel, Michael Prummer et al. · Journal for ImmunoTherapy of Cancer · 2019 · 128 citations · Full text

Medicine, Immunology, Pharmacology +17

Intratumoral budding as a potential parameter of tumor progression in mismatch repair–proficient and mismatch repair–deficient colorectal cancer patients

Alessandro Lugli, Tatjana Vlajnic, Olivier Giger et al. · Human Pathology · 2011 · 121 citations

Medicine, Cancer Biology, Oncology +17

Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens

Raphaëlle Servant, Michele Garioni, Tatjana Vlajnic et al. · The Journal of Pathology · 2021 · 80 citations · Full text

Medicine, Oncology, Urology +16

Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis

Yen‐Lin Huang, Ching-Yeu Liang, Danilo Ritz et al. · eLife · 2020 · 70 citations · Full text

Life Sciences, Cell Biology, Oncology +17